Enterprise-Wide Planning: Optimizing Research
posted February 15th, 2012
The Optimizing Research committee is working to develop a strategy to continue to ensure Duke’s role as a world-class research enterprise across the spectrum of basic, translational and clinical research.
The committee is currently working to identify the factors that comprise research success for an academic medical center, taking into account the flattening of federal research funding, the expenses incurred by the School of Medicine to conduct federally funded research, and anticipated changes associated with healthcare reform.
During the committee’s first two meetings, they analyzed the current state of research funding and historical funding trends to better understand drivers of success and where opportunities may exist to broaden our research portfolio.
Their work will include a careful review of organizational strengths and weaknesses to identify strategies to enhance Duke’s competitive advantage.
Optimizing Research Project Goals
- Define the value proposition and the goals of the School of Medicine research enterprise (encompassing basic, translational and clinical research)
- Develop a strategic plan for internally funded research that will decrease costs and increase quality
- Develop a plan to maximize research productivity in the context of the School’s financial obligations
- Develop a plan to increase research quality and productivity and to maximize external funding
- Develop a plan to maximize research administrative efficiency
Optimizing Research Team
Chair: Nancy Andrews, M.D., Ph.D., Dean, School of Medicine
Co-chair: Joe St. Geme, M.D., Chair, Department of Pediatrics
Project Lead: Bimal Shah, M.D., Department of Medicine
Rob Califf, M.D., Vice Chancellor for Clinical Research
Sol Aronson, M.D., Department of Anesthesiology
John Sampson, M.D., Department of Surgery
Mike Kastan, M.D., Ph.D., Director, Duke Cancer Institute
Tom Coffman, M.D., Department of Medicine
Holly Lisanby, M.D., Chair, Department of Psychiatry and Behavioral Sciences
Geoff Rubin, M.D., Chair, Department of Radiology
Andrew Muir, M.D., Department of Medicine
Joe Doty, Department of Medicine
Amy Murtha, M.D., Department of Obstetrics and Gynecology
Paul Noble, M.D., Department of Medicine
Mark Stacy, M.D., Vice Dean for Clinical Research
Mike Merson, M.D., Vice Chancellor, Duke-NUS, Director, Duke Global Health Institute
Chris Newgard, Ph.D., Department of Pharmacology, and Cancer Biology
Joe Heitman, M.D., Ph.D., Chair, Department of Molecular Genetics and Microbiology
Richard Brennan, Ph.D., Chair, Department of Biochemistry
John York, Ph.D., Department of Pharmacology and Cancer Biology
Jim Siedow, Ph.D., Vice Provost for Research
Monitor Group – John Matthews
Read more about the projects, goals and teams for each objective:
Click here for a Enterprise-Wide Planning project overview.
Click here to read more about Clinical Alignment.
Click here to read more about Redesigning Education.
Click here to read more about Programs of Distinction.
Visit https://intranet.mc.duke.edu/sites/ent_plan/SitePages/Home.aspx to view an Enterprise-Wide Planning presentation by Dr. Dzau and to provide comments and questions.
Commenting is not available in this weblog entry.